A Case Study on the Integrated Rehabilitation of Chemotherapy-Induced Peripheral Neuropathy in a Patient with Stage IV Breast Cancer

Main Article Content

Baneeha Zainab
Um I Lela
Kiran Shahzadi
Laiba Manzoor


Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a significant complication of cancer treatments, affecting a substantial proportion of patients and severely impacting their quality of life. Current management strategies often fall short in addressing the multifaceted nature of this condition, highlighting the need for integrated approaches that encompass physical, psychological, and social elements.

Objective: This study aimed to evaluate the efficacy of a multimodal rehabilitation program in improving physical function and psychological well-being in a patient with Stage IV breast cancer experiencing moderate CIPN.

Methods: A 40-year-old female with Stage IV breast cancer underwent a 5-week multimodal rehabilitation program, including physical therapy, psychosocial support, and mobility therapy. Assessments of grip strength, knee and shoulder flexion, neuropathic pain (DN4), anxiety and depression (HADS), and overall quality of life were conducted pre- and post-intervention using a hand dynamometer, goniometer, and standardized psychological scales.

Results: Post-treatment results demonstrated significant improvements: grip strength increased from 10 kg to 13 kg (right hand) and 9 kg to 14 kg (left hand); knee flexion improved from 120° to 129° (right) and 125° to 132° (left); shoulder flexion increased from 149° to 160° (right) and 152° to 159° (left). Psychological assessments showed a reduction in anxiety (HADS) scores from 12 to 8 and depression from 10 to 5. The DN4 score decreased from 7 to 4, indicating a reduction in neuropathic pain. Quality of life assessments also noted significant enhancements.

Conclusion: The integrated rehabilitation program was effective in significantly improving both the physical and psychological parameters in a patient with severe CIPN. This case supports the potential benefits of multidisciplinary approaches in managing CIPN, suggesting wider applicability for similar comprehensive care models in oncological rehabilitation.

Article Details

How to Cite
Zainab, B., Lela, U. I., Shahzadi, K., & Manzoor, L. (2024). A Case Study on the Integrated Rehabilitation of Chemotherapy-Induced Peripheral Neuropathy in a Patient with Stage IV Breast Cancer. Journal of Health and Rehabilitation Research, 4(2), 536–542. https://doi.org/10.61919/jhrr.v4i2.850
Author Biographies

Baneeha Zainab, GIFT University Gujranwala Pakistan.

Visiting Lecturer, M.Phil. Psychology, GIFT University Gujranwala, Pakistan.

Um I Lela, GIFT University Gujranwala Pakistan.

Associate Professor and Associate Dean, PhD Psychology, GIFT University Gujranwala, Pakistan.

Kiran Shahzadi, Gujranwala Institute of Nuclear Medicine and Radiotherapy Gujranwala Pakistan.

Consultant Oncologist, MBBS, FCPS, Gujranwala Institute of Nuclear Medicine and Radiotherapy, Gujranwala Pakistan.

Laiba Manzoor, Ripah International University Lahore Pakistan.

Orthopaedic Manual Physical Therapist, MS OMPT, Ripah International University Lahore, Pakistan.


Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol. 2015;28(5):500-7.

Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017;81(6):772-81.

Knoerl R, Weller E, Halpenny B, Berry D. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy. BMC Cancer. 2018;18(1):1203.

Suzuki K, Morishita S, Nakano J, Okayama T, Inoue J, Tanaka T, Fukushima T. Neurological Outcomes of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer: A Systematic Review and Meta-Analysis. Integrative cancer therapies. 2023 Oct;22:15347354231185110.

Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, et al. Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst. 2014;106(5).

Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. Journal of affective disorders. 2010;126(3):335-48.

Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Dico SL, et al. Neuropathic pain: clinical classification and assessment in patients with pain due to cancer. Pain. 2021;162(3):866-74.

Nuñez de Arenas‐Arroyo S, Cavero‐Redondo I, Torres‐Costoso A, Reina‐Gutiérrez S, Lorenzo‐García P, Martínez‐Vizcaíno V. Effects of exercise interventions to reduce chemotherapy‐induced peripheral neuropathy severity: a meta‐analysis. Scandinavian Journal of Medicine & Science in Sports. 2023 Jul;33(7):1040-53.

De Haes JC, Van Knippenberg FC. The quality of life of cancer patients: a review of the literature. Social science & medicine. 1985;20(8):809-17.

Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134-50.

Dan X, He YL, Tian YL, Huang Y, Ren JH. Summary of evidence on comprehensive healthcare for chemotherapy-induced peripheral neuropathy in cancer patients. Supportive Care in Cancer. 2024 Apr;32(4):264.

Nakagawa N, Yamamoto S, Hanai A, Oiwa A, Arao H. Exercise intervention for the management of chemotherapy-induced peripheral neuropathy: a systematic review and network meta-analysis. Frontiers in Neurology. 2024 Jan 30;15:1346099.

Forte AJ, Huayllani MT, Boczar D, Manrique OJ, Lu X, McLaughlin SA, et al. A Systematic Review of Peripheral Neuropathies in Breast Cancer-Related Lymphedema. Hand (N Y). 2022;17(4):668-75.

Kanzawa-Lee G, Knoerl R. What do the data say about chemotherapy-induced peripheral neuropathy assessment and management?. Asia-Pacific Journal of Oncology Nursing. 2023 Feb 1;10(2).

Kline-Quiroz C, Nori P, Stubblefield MD. Cancer rehabilitation: acute and chronic issues, nerve injury, radiation sequelae, surgical and chemo-related, part 1. Medical Clinics. 2020;104(2):239-50.

van de Graaf DL, Mols F, Smeets T, Trompetter HR, van der Lee ML. Coping with and self-management of chronic painful chemotherapy-induced peripheral neuropathy: a qualitative study among cancer survivors. Journal of Cancer Survivorship. 2023 Sep 23:1-1.

Taylor C, Tanay MA. Assessing and managing chemotherapy-induced peripheral neuropathy. Cancer Nursing Practice. 2023 Jul 3;22(4).

Wen Q, Cai X. The Construction of Integrated Nursing Model Prevention of Oxaliplatin Chemotherapy-Induced Peripheral Nerve Injury. Journal of Biosciences and Medicines. 2024 Jan 30;12(2):340-8.

Klafke N, Bossert J, Kröger B, Neuberger P, Heyder U, Layer M, Winkler M, Idler C, Kaschdailewitsch E, Heine R, John H. Prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN) with non-pharmacological interventions: clinical recommendations from a systematic scoping review and an expert consensus process. Medical Sciences. 2023 Jan 30;11(1):15.

Yesil H, Eyigör S, Caramat İ, Işık R. Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Turkish Journal of Physical Medicine and Rehabilitation. 2017;63(4):329.